Literature DB >> 25633680

Markers for the risk of progression from mild cognitive impairment to Alzheimer's disease.

Laura Buratti1, Simona Balestrini1, Claudia Altamura2, Giovanna Viticchi1, Lorenzo Falsetti3, Simona Luzzi1, Leandro Provinciali1, Fabrizio Vernieri2, Mauro Silvestrini1.   

Abstract

BACKGROUND: Defining reliable markers of conversion to dementia could be the first step in order to identify appropriate treatment strategies for mild cognitive impairment (MCI) patients.
OBJECTIVE: To develop a tool able to predict the risk of progression from MCI to Alzheimer's disease (AD).
METHODS: 406 MCI patients were included and followed for a one-year period. Demographic characteristics, vascular risk factors, extent of cerebrovascular lesions, markers of carotid atherosclerosis investigated with an ultrasonographic assessment (plaque index and intima-media thickness) and cerebrovascular reactivity to apnea (breath-holding index) were considered as potential predictors of conversion.
RESULTS: 106 (26%) MCI patients showed a conversion to AD. Plaque index, intima-media thickness, and breath-holding index were relevant predictors of conversion (p = 0.042; p = 0.003; p < 0.001, multivariate logistic regression analysis). A simplified scoring system was devised based on the magnitude of the estimated multinomial logistic regression β coefficient results. A total score was calculated as the sum of each predictive factor which resulted in a 0-5 range. The optimal cut-off score was ≥3 (sensitivity, 23.6%, 95% CI 15.9%-32.8%; specificity, 97.7%, 95% CI 95.3%-99.1%; positive likelihood ratio, 10.1, 95% CI 4.5%-22.7%; negative likelihood ratio, 0.78, 95% CI 0.70%-0.87%). The AUC was 0.71 (95% CI, 0.65-0.77).
CONCLUSIONS: Our findings show the possibility to obtain a predictive indicator of the risk of conversion from MCI to dementia by considering the presence of both atherosclerotic changes in the carotid district and impairment of cerebral hemodynamics. Such an approach may allow us to formulate a correct prognosis in more than 70% of patients with amnesic MCI.

Entities:  

Keywords:  Alzheimer's disease; atherosclerosis; carotid arteries; cerebral hemodynamics; mild cognitive impairment; ultrasonography

Mesh:

Substances:

Year:  2015        PMID: 25633680     DOI: 10.3233/JAD-143135

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  17 in total

Review 1.  Exercise Training for Persons with Alzheimer's Disease and Caregivers: A Review of Dyadic Exercise Interventions.

Authors:  Guillaume Lamotte; Raj C Shah; Orly Lazarov; Daniel M Corcos
Journal:  J Mot Behav       Date:  2016-11-21       Impact factor: 1.328

2.  Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.

Authors:  Thomas Polak; Martin J Herrmann; Laura D Müller; Julia B M Zeller; Andrea Katzorke; Matthias Fischer; Fabian Spielmann; Erik Weinmann; Leif Hommers; Martin Lauer; Andreas J Fallgatter; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

3.  Reduced global brain metabolism but maintained vascular function in amnestic mild cognitive impairment.

Authors:  Binu P Thomas; Min Sheng; Benjamin Y Tseng; Takashi Tarumi; Kristen Martin-Cook; Kyle B Womack; Munro C Cullum; Benjamin D Levine; Rong Zhang; Hanzhang Lu
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

4.  Redox modulation of cellular stress response and lipoxin A4 expression by Hericium Erinaceus in rat brain: relevance to Alzheimer's disease pathogenesis.

Authors:  A Trovato; R Siracusa; R Di Paola; M Scuto; M L Ontario; Ornella Bua; Paola Di Mauro; M A Toscano; C C T Petralia; L Maiolino; A Serra; S Cuzzocrea; Vittorio Calabrese
Journal:  Immun Ageing       Date:  2016-07-09       Impact factor: 6.400

Review 5.  Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's disease.

Authors:  Branko Malojcic; Panteleimon Giannakopoulos; Farzaneh A Sorond; Elsa Azevedo; Marina Diomedi; Janja Pretnar Oblak; Nicola Carraro; Marina Boban; Laszlo Olah; Stephan J Schreiber; Aleksandra Pavlovic; Zsolt Garami; Nantan M Bornstein; Bernhard Rosengarten
Journal:  BMC Med       Date:  2017-02-09       Impact factor: 8.775

6.  Markers of arterial health could serve as accurate non-invasive predictors of human biological and chronological age.

Authors:  Alexander Fedintsev; Daria Kashtanova; Olga Tkacheva; Irina Strazhesko; Anna Kudryavtseva; Ancha Baranova; Alexey Moskalev
Journal:  Aging (Albany NY)       Date:  2017-04       Impact factor: 5.682

7.  Hemodynamic correlates of transient cognitive impairment after transient ischemic attack and minor stroke: A transcranial Doppler study.

Authors:  Sara Mazzucco; Linxin Li; Maria A Tuna; Sarah T Pendlebury; Rose Wharton; Peter M Rothwell
Journal:  Int J Stroke       Date:  2016-07-26       Impact factor: 5.266

8.  Ultrasound Markers of Carotid Atherosclerosis and Cognition: The Northern Manhattan Study.

Authors:  Hannah Gardener; Michelle R Caunca; Chuanhui Dong; Ying Kuen Cheung; Mitchell S V Elkind; Ralph L Sacco; Tatjana Rundek; Clinton B Wright
Journal:  Stroke       Date:  2017-06-19       Impact factor: 7.914

9.  Selecting the most important self-assessed features for predicting conversion to mild cognitive impairment with random forest and permutation-based methods.

Authors:  Jaime Gómez-Ramírez; Marina Ávila-Villanueva; Miguel Ángel Fernández-Blázquez
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

10.  Regional MRI Diffusion, White-Matter Hyperintensities, and Cognitive Function in Alzheimer's Disease and Vascular Dementia.

Authors:  Claudia Altamura; Federica Scrascia; Carlo Cosimo Quattrocchi; Yuri Errante; Emma Gangemi; Giuseppe Curcio; Francesca Ursini; Mauro Silvestrini; Paola Maggio; Bruno Beomonte Zobel; Paolo Maria Rossini; Patrizio Pasqualetti; Lorenzo Falsetti; Fabrizio Vernieri
Journal:  J Clin Neurol       Date:  2016-04       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.